Anti-Inflammatory Therapeutics Market Growth Is Reshaping Competitive Advantage Across The Industry
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Anti-Inflammatory Therapeutics Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The anti-inflammatory therapeutics market has experienced consistent expansion in recent years, with projections indicating a rise from $117.28 billion in 2025 to $122.27 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.3%. This historical growth has been driven by several key factors, including a higher incidence of arthritis, an increase in chronic inflammatory bowel diseases, the expansion of hospital pharmacy networks, broader adoption of corticosteroid therapies, and a sustained demand for pain management medications.
The market for anti-inflammatory therapeutics is projected to experience significant expansion over the coming years, reaching an estimated value of $152.04 billion by 2030, with a compound annual growth rate (CAGR) of 5.6%. This anticipated growth during the forecast period is driven by factors such as the development of targeted biologic treatments, the incorporation of artificial intelligence into drug discovery, the growing presence of online pharmacies, the rising number of elderly individuals, and an increased emphasis on personalized medicine. Key trends shaping this period include the emergence of customized anti-inflammatory therapies, a greater reliance on biologic drugs, the adoption of less invasive drug delivery methods, a heightened focus on managing chronic pain, and the widening scope of online pharmaceutical distribution channels.
Download A Free Sample Report For Comprehensive Market Insights:
Anti-Inflammatory Therapeutics Market Industry Drivers: What Is Driving Revenue Growth?
The rising occurrence of inflammatory bowel disease is anticipated to boost the expansion of the anti-inflammatory therapeutics market in the coming years. Inflammatory bowel disease (IBD) represents a chronic condition marked by gastrointestinal tract inflammation. Anti-inflammatory therapeutics are essential for managing Crohn’s disease, as they help diminish inflammation, alleviate disease symptoms, and lower the likelihood of surgical intervention. As an example, in June 2023, Crohn’s and Colitis Canada, a nonprofit organization based in Canada, projected that the number of IBD patients in Canada would reach 470,000 by 2035, compared to an estimated 322,600 in 2023. Consequently, the growing prevalence of inflammatory bowel disease is fueling the advancement of the anti-inflammatory therapeutics market.
Anti-Inflammatory Therapeutics Market Segment Landscape And Growth Potential
The anti-inflammatory therapeutics market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
Anti-Inflammatory Therapeutics Market Growth Trends: What Is Influencing The Future Outlook?
Leading players in the anti-inflammatory therapeutics market are concentrating on the creation of cutting-edge biologic treatments aimed at enhancing outcomes for individuals suffering from persistent inflammatory disorders. These sophisticated therapies are engineered to deliver precise immune system regulation, superior effectiveness, and improved patient tolerance when compared to standard options like corticosteroids. As an example, in February 2023, Regeneron Pharmaceuticals Inc., a biotechnology firm based in the United States, along with Sanofi, a pharmaceutical and healthcare company from France, introduced Kevzara (sarilumab), which stands as the inaugural and exclusive anti-inflammatory biologic recommended for adult patients diagnosed with polymyalgia rheumatica (PMR) who either have an insufficient response to corticosteroids or cannot manage corticosteroid dose reduction. This innovative IL-6 receptor blocker presents a more potent and corticosteroid-reducing therapeutic choice, tackling a considerable unmet requirement in PMR care, thereby reinforcing the market standing of these companies within the anti-inflammatory therapeutics sector.
Anti-Inflammatory Therapeutics Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co. Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
Access The Complete Anti-Inflammatory Therapeutics Market Report:
Anti-Inflammatory Therapeutics Market Geographic Distribution And Regional Opportunities
North America was the largest region in the anti-inflammatory therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
